Literature DB >> 34107067

Deletion of TLR2+ erythro-myeloid progenitors leads to embryonic lethality in mice.

Iva Splichalova1, Jana Balounová1,2, Matouš Vobořil1, Tomas Brabec1, Radislav Sedlacek2, Dominik Filipp1.   

Abstract

Early embryonic hematopoiesis in mammals is defined by three successive waves of hematopoietic progenitors which exhibit a distinct hematopoietic potential and provide continuous support for the development of the embryo and adult organism. Although the functional importance of each of these waves has been analyzed, their spatio-temporal overlap and the lack of wave-specific markers hinders the accurate separation and assessment of their functional roles during early embryogenesis. We have recently shown that TLR2, in combination with c-kit, represents the earliest signature of emerging precursors of the second hematopoietic wave, erythro-myeloid precursors (EMPs). Since the onset of Tlr2 expression distinguishes EMPs from primitive progenitors which coexist in the yolk sac from E7.5, we generated a novel transgenic "knock in" mouse model, Tlr2Dtr , suitable for inducible targeted depletion of TLR2+ EMPs. In this model, the red fluorescent protein and diphtheria toxin receptor sequences are linked via a P2A sequence and inserted into the Tlr2 locus before its stop codon. We show that a timely controlled deletion of TLR2+ EMPs in Tlr2Dtr embryos results in a marked decrease in both erythroid as well as myeloid lineages and, consequently, in embryonic lethality peaking before E13.5. These findings validate the importance of EMPs in embryonic development.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  EMP; TLR2; embryo; hematopoiesis; lethality

Year:  2021        PMID: 34107067     DOI: 10.1002/eji.202049142

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  1 in total

1.  Ezh2 is essential for the generation of functional yolk sac derived erythro-myeloid progenitors.

Authors:  Wen Hao Neo; Yiran Meng; Alba Rodriguez-Meira; Muhammad Z H Fadlullah; Christopher A G Booth; Emanuele Azzoni; Supat Thongjuea; Marella F T R de Bruijn; Sten Eirik W Jacobsen; Adam J Mead; Georges Lacaud
Journal:  Nat Commun       Date:  2021-12-02       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.